Furthermore, aberrantly expressed miRNAs were reported in different stages of NAFLD, highly supporting the possibility of the existence of certain miRNA in regulating HDMCP expression. The gene discussed is SLC25A47; the disease is metabolic dysfunction-associated steatotic liver disease.